Welcome to BaseLaunch
We partner with scientists and entrepreneurs to help launch and grow exceptional biotech ventures developing cutting-edge therapeutics. And we know how to do this – so far our portfolio has raised over $800M in financing with an average first VC round of over $28M per company.
Up to $500,000
in financing
Access to our partners,
global biopharma & investors
Company & team
build out
Access to labs &
related infrastructure
where needed
Latest news

Gibela Publishes New Findings on CNNM4 in Metabolic Disease
Gibela Publishes New Findings on CNNM4 in Metabolic Disease

Tolremo Announces Positive TT125-802 Results at ESMO 2025
Tolremo Announces Positive TT125-802 Results at ESMO 2025

Alentis appoints Dr. Mark Pruzanski as CEO
Alentis appoints Dr. Mark Pruzanski as CEO

Synendos Reports Positive Phase 1 Results for SYT-510, Preparing for Phase 2
Synendos Reports Positive Phase 1 Results for SYT-510, Preparing for Phase 2

metaLead Therapeutics Appoints David Urech as Member of the Board of Directors
metaLead Therapeutics Appoints David Urech as Member of the Board of Directors

Gibela publishes groundbreaking research in Hepatology